Table I. Average ages, MMSE scores, and serum ApoE levels determined via FACS and SRM (mean ± S.D.).
AD |
Control |
|||||
---|---|---|---|---|---|---|
All (n + 45) | Male (n + 17) | Female (n + 28) | All (n + 43) | Male (n + 26) | Female (n + 17) | |
Age (years) | 73.29 ± 9.74 | 72.71 ± 9.33 | 73.64 ± 10.13 | 73.53 ± 4.11 | 73.62 ± 4.22 | 73.41 ± 4.08 |
MMSE score | 16.11 ± 6.49 | 17.77 ± 6.11 | 15.11 ± 6.62 | |||
FACS (normalization) | 1.67 ± 0.90 | 1.77 ± 0.93 | 1.62 ± 0.90 | 2.68 ± 1.13 | 2.79 ± 1.04 | 2.53 ± 1.26 |
FACS (concentration) (mg.l) | 10.22 ± 5.27 | 10.77 ± 5.43 | 9.88 ± 5.24 | 16.13 ± 6.57 | 16.73 ± 6.08 | 15.21 ± 7.36 |
SRM (LGP) (mg/l) | 36.41 ± 11.22 | 34.48 ± 9.18 | 37.58 ± 12.31 | 49.50 ± 16.97 | 47.36 ± 15.90 | 52.76 ± 18.51 |
SRM (AAT) | 26.27 ± 8.57 | 23.03 ± 6.24 | 28.24 ± 9.27 | 31.49 ± 11.26 | 29.37 ± 10.67 | 34.74 ± 11.69 |
ApoE FACS normalization: arbitrary quantification unit by normalized mean fluorescence intensity. LGP, LGPLVEQGR; AAT, AATVGSLAGQPLQER.